BIOMAT Database Logo BIOMAT Database Logo

Inhibitors of HIV-1 protease containing the novel and potent (R)-(hydroxyethyl)sulfonamide isostere. 1995

M L Vazquez, and M L Bryant, and M Clare, and G A DeCrescenzo, and E M Doherty, and J N Freskos, and D P Getman, and K A Houseman, and J A Julien, and G P Kocan
Searle Discovery Research, Skokie, Illinois 60077.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

M L Vazquez, and M L Bryant, and M Clare, and G A DeCrescenzo, and E M Doherty, and J N Freskos, and D P Getman, and K A Houseman, and J A Julien, and G P Kocan
Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.
July 1997, Journal of medicinal chemistry,
M L Vazquez, and M L Bryant, and M Clare, and G A DeCrescenzo, and E M Doherty, and J N Freskos, and D P Getman, and K A Houseman, and J A Julien, and G P Kocan
Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostere.
January 1993, Journal of medicinal chemistry,
M L Vazquez, and M L Bryant, and M Clare, and G A DeCrescenzo, and E M Doherty, and J N Freskos, and D P Getman, and K A Houseman, and J A Julien, and G P Kocan
Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere.
March 1998, Bioorganic & medicinal chemistry letters,
M L Vazquez, and M L Bryant, and M Clare, and G A DeCrescenzo, and E M Doherty, and J N Freskos, and D P Getman, and K A Houseman, and J A Julien, and G P Kocan
A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity.
July 1992, Journal of medicinal chemistry,
M L Vazquez, and M L Bryant, and M Clare, and G A DeCrescenzo, and E M Doherty, and J N Freskos, and D P Getman, and K A Houseman, and J A Julien, and G P Kocan
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere.
August 2020, Journal of medicinal chemistry,
M L Vazquez, and M L Bryant, and M Clare, and G A DeCrescenzo, and E M Doherty, and J N Freskos, and D P Getman, and K A Houseman, and J A Julien, and G P Kocan
Structure-activity relationship of orally potent tripeptide-based HIV protease inhibitors containing hydroxymethylcarbonyl isostere.
September 2000, Chemical & pharmaceutical bulletin,
M L Vazquez, and M L Bryant, and M Clare, and G A DeCrescenzo, and E M Doherty, and J N Freskos, and D P Getman, and K A Houseman, and J A Julien, and G P Kocan
Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere.
November 1991, Journal of medicinal chemistry,
M L Vazquez, and M L Bryant, and M Clare, and G A DeCrescenzo, and E M Doherty, and J N Freskos, and D P Getman, and K A Houseman, and J A Julien, and G P Kocan
Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands.
December 1998, Bioorganic & medicinal chemistry letters,
M L Vazquez, and M L Bryant, and M Clare, and G A DeCrescenzo, and E M Doherty, and J N Freskos, and D P Getman, and K A Houseman, and J A Julien, and G P Kocan
Studies of human immunodeficiency virus type 1 (HIV-1) protease inhibitors. III. Structure-activity relationship of HIV-1 protease inhibitors containing cyclohexylalanylalanine hydroxyethylene dipeptide isostere.
March 1994, Chemical & pharmaceutical bulletin,
M L Vazquez, and M L Bryant, and M Clare, and G A DeCrescenzo, and E M Doherty, and J N Freskos, and D P Getman, and K A Houseman, and J A Julien, and G P Kocan
Design and synthesis of pseudo-symmetric HIV protease inhibitors containing a novel hydroxymethylcarbonyl (HMC)-hydrazide isostere.
January 2003, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!